Procodazole; 23249-97-0; 2-Benzimidazolepropionic acid; 3-(1H-Benzimidazol-2-yl)propanoic acid; Propazol; 1H-Benzimidazole-2-propanoic acid; Procodazol; Estimulocel; Procodazole [INN]; Propazole; 3-(1H-benzo[d]imidazol-2-yl)propanoic acid; 2-(2-Carboxyethyl)benzimidazole; NSC35790; NSC 35790; NSC-35790; 3-(1H-Benzoimidazol-2-yl)-propionic acid; 3-(1H-1,3-Benzodiazol-2-Yl)Propanoic Acid; SG5IU7FD3R; AL-1241; Propionic acid, 2-(2-benzimidazolyl)-; CHEMBL596009; DTXSID5045093; Propazol;2-Benzimidazolepropionic acid; NCGC00013414-03; DTXCID3025093; Procodazolum; Procodazol [INN-Spanish]; Procodazolum [INN-Latin]; CAS-23249-97-0; UNII-SG5IU7FD3R; beta-(2-Benzimidazole)propionic acid; beta-(2-Benzimidazolyl)propionic acid; BRN 0156920; 4BX; Estimulocel (Salt/Mix); PROCODAZOLE [MI]; NCIStruc1_000049; NCIStruc2_000216; PROCODAZOLE [MART.]; Oprea1_461552; Oprea1_527552; PROCODAZOLE [WHO-DD]; 5-25-04-00311 (Beilstein Handbook Reference); SCHEMBL349966; 2-benzimidazole propionic acid; 2-benzimidazole-propionic acid; IFLab1_003962; ZINC51581; 1H-Benzimidazole-2-propanoicacid; CHEBI:134840; HMS1423E02; HMS3264A18; Pharmakon1600-01506175; 2-BENZIMIDAZOLEPROPIONICACID; ALBB-016689; HY-B1056; NCI35790; 2-Benzimidazolepropionic acid, 97%; Tox21_110025; BBL004542; BDBM50305668; CCG-36559; MFCD00041215; NCGC00013414; NSC760399; s4408; STK387005; AKOS000200796; Tox21_110025_1; CS-4578; NSC-760399; .beta.-(2-Benzimidazole)propionic acid; Propionic acid, 3-(2-benzimidazolyl)-; .beta.-(2-Benzimidazolyl)propionic acid; NCGC00013414-02; NCGC00013414-04; NCGC00096529-01; NCGC00096529-02; BP-13182; CS-10157; NCI60_003248; TS-02680; 3-(1H-Benzimidazol-2-yl)propanoic acid #; 3-(1H-benzo[d]imidazol-2-yl)propanoicacid; Et2-N-4,5,6,7-4HBzthiophene carboxylate; BB 0219682; FT-0688794; SW219817-1; EN300-13260; E78041; AB00442573-04; AB00442573_05; AB00442573_06; SR-01000944283; J-640101; J-800103; SR-01000944283-1; BRD-K54824716-001-01-6; Q27289198; Z57115077; F0852-0156